Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion type Assertion NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_head.
- NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion wasGeneratedBy ECO_0000203 NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_provenance.
- NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion wasDerivedFrom befree-2016 NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_provenance.
- NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion SIO_000772 19708722 NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_provenance.
- NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion evidence source_evidence_literature NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_provenance.
- NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_assertion description "[The new antidepressant agomelatine is the first melatonergic antidepressant with an innovative mode of action: it is a melatonergic MT(1), MT(2) receptor agonist and 5-HT(2c) antagonist, and is able to restore the internal clock, which is profoundly disturbed in depression, thus being efficacious in major depressive disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP759636.RAIWZ1MU-XcRJaMXqE5ho4oxxFIOdEEDKXEJr7_yTNcyo130_provenance.